Presentations From the Third Annual ASH Review Symposium
On January 16, 2010, the Vanderbilt-Ingram Cancer Center held the Third Annual ASH Review Symposium. Here are PDF versions of the Powerpoint presentations for you to view and print.
- Chronic Myeloid Leukemia: After a Decade of Imatinib
Dale Bixby, M.D., Ph.D.
Clinical Assistant Professor
Assistant Program Director
Division of Hematology and Oncology
Department of Internal Medicine
University of Michigan - Emerging Strategies for the Treatment of Acute Myeloid Leukemia: Progress and Challenges
Stephen Strickland, MD
A ssistant Professor of Medicine
Vanderbilt-Ingram Cancer Center - Multiple Myeloma: New Standards for Induction Therapy and Role of Maintenance
Sergio Giralt, M.D.
Professor of Medicine
University of Texas M.D. Anderson Cancer Center - Arterial Events in Patients with VTE
David Green, MD, PhD
Professor, Emeritus in Medicine, Hematology/Oncology
Northwestern Universtiy Feinberg School of Medicine - Thrombocytopenia 2010 : ITP, TTP and HIT
Anne T. Neff, MD
Assistant Professor of Medicine
Vanderbilt-Ingram Cancer Center - Myeloproliferative Disorders: Management and Therapeutic Potential of JAK2 Inhibitors (Philadelphia chromosome negative – ET/PV/MF)
Adetola A. Kassim, MD
Assistant Professor of Medicine
Vanderbilt-Ingram Cancer Center - Pitfalls and Progress in Hodgkin Lymphoma - 2010
John Greer, MD
Professor of Medicine
Vanderbilt-Ingram Cancer Center - Management of Aggressive B- cell Lymphomas: Clinical Conundrums
Nishitha Reddy, MD
Assistant Professor of Medicine
Vanderbilt-Ingram Cancer Center - Effective Therapeutic Decision Making in Myelodysplastic Syndrome: Improving Patient Outcomes and Quality of Life
Madan Jagasia, MD
Assistant Professor of Medicine
Vanderbilt-Ingram Cancer Center - Allogeneic Hemotopoietic Cell Transplantation: Focus on Lymphoproliferative Disorders
Friedrich Schuening, MD
Professor of Medicine; Section Chief
Vanderbilt-Ingram Cancer Center
